NCT02332174View on ClinicalTrials.gov

Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Seizures
Interventions
DRUG

rufinamide

comparison of different doses, sex and medication conditions

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

NCT02332174 - Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter